Login or sign up
For business

QUE Oncology

3.9Β· 11 reviews
Average ratingAverage
3.9/ 5

Based on 11 reviews

527%
436%
336%
20%
10%
Ask AI

Ask AI about QUE Oncology

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Sangjoon Park
Reviews 1

I recently used the services of a company I found online. Their expertise and professionalism were impressive. The staff was knowledgeable and provided me with all the information I needed. I would highly recommend them to anyone seeking quality healthcare services.

Scott Clayton
Reviews 1

The service provided by QUE Oncology is great. I am very satisfied with the professional staff and their expertise. They were able to address all my concerns and provide me with the necessary information. I highly recommend QUE Oncology to anyone seeking quality healthcare services.

Anelisa Hlongwane
Reviews 1

I recently had a great experience with a healthcare provider. The staff was very professional and knowledgeable. They took the time to address all my concerns and provided me with the necessary information. I am highly satisfied with the service I received.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About QUE Oncology

QUE Oncology, Inc. (QUE) was formed through a collaboration between Emory University, in Atlanta, Georgia, and The University of Queensland (UQ) research commercialization company, UniQuest, in Brisbane, Australia.

QUE licenses intellectual property originating from research discoveries at both UQ and Emory’s Institute for Drug Development (EIDD). The leading drug candidate is Q-122, a compound with anti-inflammatory properties that is in Phase 1b clinical development for the treatment of hot flashes in women with breast cancer who are receiving anti-estrogen therapy. Additional cancer research projects that have been identified to supply the QUE Oncology pipeline are designed to address prostate cancer, breast cancer, melanoma, and cancer pain.